Browsing publications by Dr Rachel Crossland

Newcastle AuthorsTitleYearFull text
Sadaf Atarod
Dr Kim Pearce
Jean Norden
Dr Clare Lendrem
Dr Rachel Crossland
et al.
Differential microRNA expressions in cutaneous acute graft-versus-host disease2015
Rihab Gam
Jean Norden
Dr Rachel Crossland
Dr Kim Pearce
Professor Anne Dickinson
et al.
IRAK1 and miR-146a for predicting the outcome of allogeneic haematopoietic stem cell transplantation2015
Rihab Gam
Jean Norden
Dr Rachel Crossland
Dr Kim Pearce
Professor Anne Dickinson
et al.
MICA genotype, serum and expression level effects on the outcome of HSCT2015
Dr Christopher Carey
Dr Rachel Crossland
Dr Christopher Bacon
Dr Vikki Rand
Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens2015
Dr Vikki Rand
Stephen Johnstone
Dr Rachel Crossland
Sarah Wilkinson
Professor Andy Hall
et al.
The Genomic Landscape of Relapsed B-Cell Acute Lymphoblastic Leukaemia (B-ALL) in Adolescents and Adults2014
Dr Rachel Crossland
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease2014
Dr Rachel Crossland
Jean Norden
Louis Bibby
Joanna Davis
Professor Anne Dickinson
et al.
Validation of Isolation Methodology and Endogenous Control Selection for qRT-PCR Assessment of Microrna Expression in Serum and Urine Exosomes2014
Dr Rachel Crossland
Dr Michal Sieniawski
S Parimala A Saminathan
Dr Tryfonia Mainou-Fowler
MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies2013
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Paul Milne
et al.
Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients2013
Dr Rachel Crossland
The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukemia and of survival following first-line chemotherapy2013
12